Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-06T00:59:33.744Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk Factors for In-Hospital Mortality among a Cohort of Children with Clostridium difficile Infection

Published online by Cambridge University Press:  02 July 2015

Neika Vendetti ,
Theoklis Zaoutis ,
Susan E. Coffin  and
Julia Shaklee Sammons
Neika Vendetti*
Affiliation:
Division of Infectious Disease, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Theoklis Zaoutis
Affiliation:
Division of Infectious Disease, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Susan E. Coffin
Affiliation:
Division of Infectious Disease, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania Department of Infection Prevention and Control, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Julia Shaklee Sammons
Affiliation:
Division of Infectious Disease, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania Department of Infection Prevention and Control, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
*
Address correspondence to Neika Vendetti, MPH, Division of Infectious Diseases, The Children’s Hospital of Philadelphia, 3535 Market St. Rm 1519, Philadelphia, PA 19104 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

The incidence of Clostridium difficile infection (CDI) has increased and has been associated with poor outcomes among hospitalized children, including increased risk of death. The purpose of this study was to identify risk factors for all-cause in-hospital mortality among children with CDI.

METHODS

A multicenter cohort of children with CDI, aged 1–18 years, was established among children hospitalized at 41 freestanding children’s hospitals between January 1, 2006 and August 31, 2011. Children with CDI were identified using a validated case-finding tool (ICD-9-CM code for CDI plus C. difficile test charge). Only the first CDI-related hospitalization during the study period was used. Risk factors for all-cause in-hospital mortality within 30 days of C. difficile test were evaluated using a multivariable logistic regression model.

RESULTS

We identified 7,318 children with CDI during the study period. The median age of this cohort was 6 years [interquartile range (IQR): 2–13]; the mortality rate was 1.5% (n=109); and the median number of days between C. difficile testing and death was 12 (IQR, 7–20). Independent risk factors for death included older age [adjusted odds ratio (OR, 95% confidence interval), 2.29 (1.40–3.77)], underlying malignancy [3.57 (2.36–5.40)], cardiovascular disease [2.06 (1.28–3.30)], hematologic/immunologic condition [1.89 (1.05–3.39)], gastric acid suppression [2.70 (1.43–5.08)], and presence of >1 severity of illness marker [3.88 (2.44–6.19)].

CONCLUSION

Patients with select chronic conditions and more severe disease are at increased risk of death. Identifying risk factors for in-hospital mortality can help detect subpopulations of children that may benefit from targeted CDI prevention and treatment strategies.

Infect Control Hosp Epidemiol 2015;36(10):1183–1189

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 10 , October 2015 , pp. 1183 - 1189
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.CrossRefGoogle Scholar
2. Dubberke, ER, Gerding, DN, Classen, D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S81–S92.CrossRefGoogle ScholarPubMed
3. Kim, J, Smathers, SA, Prasad, P, Leckerman, KH, Coffin, S, Zaoutis, T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children’s hospitals in the United States, 2001–2006. Pediatrics 2008;122:1266–1270.CrossRefGoogle ScholarPubMed
4. Zilberberg, MD, Shorr, AF, Kollef, MH. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000–2005. Pediatr Infect Dis J 2008;27:1111–1113.CrossRefGoogle ScholarPubMed
5. Nylund, CM, Goudie, A, Garza, JM, Fairbrother, G, Cohen, MB. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011;165:451–457.CrossRefGoogle ScholarPubMed
6. Elliott, B, Chang, BJ, Golledge, CL, Riley, TV. Clostridium difficile-associated diarrhoea. Intern Med J 2007;37:561–568.CrossRefGoogle ScholarPubMed
7. McFarland, LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Gastroenterol Hepatol 2008;5:40–48.CrossRefGoogle ScholarPubMed
8. Sammons, JS, Toltzis, P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr 2013;25:116–121.CrossRefGoogle ScholarPubMed
9. Sammons, JS, Localio, R, Xiao, R, Coffin, SE, Zaoutis, T. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013;57:1–8.CrossRefGoogle ScholarPubMed
10. Shaklee, J, Zerr, DM, Elward, A, et al. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr Infect Dis J 2011;30:e38–e40.CrossRefGoogle ScholarPubMed
11. Feudtner, C, Christakis, DA, Zimmerman, FJ, Muldoon, JH, Neff, JM, Koepsell, TD. Characteristics of deaths occurring in children’s hospitals: implications for supportive care services. Pediatrics 2002;109:887–893.CrossRefGoogle ScholarPubMed
12. Abou Chakra, CN, Pepin, J, Sirard, S, Valiquette, L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PloS One 2014;9:e98400.CrossRefGoogle ScholarPubMed
13. Hardt, C, Berns, T, Treder, W, Dumoulin, FL. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroentero 2008;14:4338–4341.CrossRefGoogle ScholarPubMed
14. Kim, ES, Kim, YJ, Park, CW, et al. Response failure to the treatment of Clostridium difficile infection and its impact on 30-day mortality. Hepato-gastroenterol 2013;60:543–548.Google Scholar
15. de Blank, P, Zaoutis, T, Fisher, B, Troxel, A, Kim, J, Aplenc, R. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013;163:699–705.CrossRefGoogle ScholarPubMed
16. Tai, E, Richardson, LC, Townsend, J, Howard, E, McDonald, LC. Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 2011;30:610–612.CrossRefGoogle ScholarPubMed
17. Khanna, S, Aronson, SL, Kammer, PP, Baddour, LM, Pardi, DS. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study. Mayo Clin Proc 2012;87:636–642.CrossRefGoogle ScholarPubMed
18. Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989–2995.CrossRefGoogle ScholarPubMed
19. Deshpande, A, Pant, C, Pasupuleti, V, et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol 2012;10:225–2233.CrossRefGoogle ScholarPubMed
20. Kwok, CS, Arthur, AK, Anibueze, CI, Singh, S, Cavallazzi, R, Loke, YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastoenterol 2012;107:1011–1019.CrossRefGoogle ScholarPubMed
21. Janarthanan, S, Ditah, I, Adler, DG, Ehrinpreis, MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastoenterol 2012;107:1001–1010.CrossRefGoogle ScholarPubMed
22. Turco, R, Martinelli, M, Miele, E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010;31:754–759.CrossRefGoogle ScholarPubMed
23. Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.CrossRefGoogle ScholarPubMed
24. Pepin, J, Saheb, N, Coulombe, MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254–1260.CrossRefGoogle ScholarPubMed
25. Drudy, D, Harnedy, N, Fanning, S, Hannan, M, Kyne, L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile . Infect Control Hosp Epidemiol 2007;28:932–940.CrossRefGoogle ScholarPubMed
26. Gopal Rao, G, Mahankali Rao, CS, Starke, I. Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy. J Antimicrob Chemother 2003;51:697–701.CrossRefGoogle ScholarPubMed
27. Thibault, A, Miller, MA, Gaese, C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12:345–348.CrossRefGoogle ScholarPubMed
28. Vesta, KS, Wells, PG, Gentry, CA, Stipek, WJ. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Am J Infect Control 2005;33:469–472.CrossRefGoogle ScholarPubMed
29. Fernandez, A, Anand, G, Friedenberg, F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004;38:414–418.CrossRefGoogle ScholarPubMed
30. Zar, FA, Bakkanagari, SR, Moorthi, KM, Davis, MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302–307.CrossRefGoogle ScholarPubMed
31. Musher, DM, Aslam, S, Logan, N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586–1590.CrossRefGoogle ScholarPubMed
32. Pepin, J, Alary, ME, Valiquette, L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591–1597.CrossRefGoogle ScholarPubMed
33. Belmares, J, Gerding, DN, Parada, JP, Miskevics, S, Weaver, F, Johnson, S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007;55:495–501.CrossRefGoogle ScholarPubMed
34. Al-Nassir, WN, Sethi, AK, Nerandzic, MM, Bobulsky, GS, Jump, RL, Donskey, CJ. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008;47:56–62.CrossRefGoogle ScholarPubMed
35. Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis 2014;59:345–354.CrossRefGoogle ScholarPubMed
36. Zilberberg, MD, Reske, K, Olsen, M, Yan, Y, Dubberke, ER. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 2014;14:306.CrossRefGoogle ScholarPubMed
37. Eyre, DW, Walker, AS, Wyllie, D, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012;55:S77–S87.CrossRefGoogle ScholarPubMed
38. Freedberg, DE, Salmasian, H, Friedman, C, Abrams, JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol 2013;108:1794–1801.CrossRefGoogle ScholarPubMed